首页> 外文期刊>Current clinical pharmacology >Alcohol consumption, dementia and cognitive decline: An overview of systematic reviews
【24h】

Alcohol consumption, dementia and cognitive decline: An overview of systematic reviews

机译:饮酒,痴呆和认知能力下降:系统评价概述

获取原文
获取原文并翻译 | 示例
           

摘要

There is uncertainty in relation to the effect of alcohol consumption on the incidence of dementia and cognitive decline. This review critically evaluated published systematic reviews on the epidemiology of alcohol consumption and the risk of dementia or cognitive decline. MEDLINE, EMBASE and PsycINFO were searched from inception to February 2014. Systematic reviews of longitudinal observational studies were considered. Two reviewers independently completed the 11-item Assessment of Multiple Systematic Reviews (AMSTAR) tool to assess the quality. We identified three moderate quality systematic reviews (AMSTAR score 4-6) that included a total of 45 unique studies. Two of the systematic reviews encompassed a meta-analysis. Light to moderate drinking may decrease the risk of Alzheimer’s disease (AD) (pooled risk ratio [RR] 0.72; 95% confidence interval [CI] 0.61-0.86) and dementia (RR 0.74; 95%CI 0.61-0.91) whereas heavy to excessive drinking does not affect the risk (RR 0.92; 95%CI 0.59-1.45 and RR 1.04; 95%CI 0.69-1.56, respectively). One systematic review identified two studies that reported a link between alcohol consumption and the development of AD. No systematic review categorised former drinkers separately from lifetime abstainers in their analysis. Definitions of alcohol consumption, light to moderate drinking and heavy-excessive drinking varied and drinking patterns were not considered. Moderate quality (AMSTAR score 4-6) systematic reviews indicate that light to moderate alcohol consumption may protect against AD and dementia. However, the importance of drinking patterns and specific beverages remain unknown. There is insufficient evidence to suggest abstainers should initiate alcohol consumption to protect against dementia.
机译:饮酒对痴呆症和认知能力下降的影响尚不确定。该评价严格评估了关于饮酒的流行病学和痴呆或认知能力下降的风险的已发表的系统评价。从开始到2014年2月,对MEDLINE,EMBASE和PsycINFO进行了搜索。考虑了对纵向观察研究的系统评价。两名审稿人独立完成了11个项目的多系统审阅评估(AMSTAR)工具,以评估质量。我们确定了三项中等质量的系统评价(AMSTAR评分4-6),其中包括45项独特的研究。其中两项系统评价包括一项荟萃分析。轻度至中度饮酒可降低阿尔茨海默氏病(AD)(合并风险比[RR] 0.72; 95%置信区间[CI] 0.61-0.86)和痴呆症(RR 0.74; 95%CI 0.61-0.91)的风险,而重度至过量饮酒不会影响风险(分别为RR 0.92; 95%CI 0.59-1.45和RR 1.04; 95%CI 0.69-1.56)。一项系统评价确定了两项研究,这些研究报告了饮酒与AD的发展之间的联系。没有系统的评论将前饮酒者与终身戒酒者分开进行分析。饮酒,轻度至中度饮酒和重度过度饮酒的定义各不相同,没有考虑饮酒方式。中等质量(AMSTAR评分4-6)的系统评价表明,轻度至中度饮酒可以预防AD和痴呆。然而,饮用方式和特定饮料的重要性仍然未知。没有足够的证据表明戒酒者应开始饮酒以预防痴呆。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号